MB LAB Revise Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| 0 |
| -427 |
| -427 |
| -427 |
| - |
| - |
| -377 |
| 400 |
| 0 |
| 23 |
| - |
| -1.06 |
| - |
| - |
| - |
| -427 |
| 2024 |
|---|
| 0 |
| 0 |
| -922 |
| -922 |
| -922 |
| - |
| - |
| -1,299 |
| 1,300 |
| 0 |
| 1 |
| - |
| -1.00 |
| - |
| - |
| - |
| -922 |
| 2025 |
|---|
| 14,880 |
| 14,880 |
| 16,351 |
| 15,450 |
| 15,450 |
| 100.00 |
| 103.83 |
| 14,151 |
| 973 |
| 0 |
| 15,124 |
| 0.95 |
| 0.07 |
| - |
| - |
| 86.62 |
| 12,889 |
| 2025 |
|---|
| 14,880 |
| 14,880 |
| 16,351 |
| 15,450 |
| 15,450 |
| 100.00 |
| 103.83 |
| 14,151 |
| 973 |
| 0 |
| 15,124 |
| 0.95 |
| 0.07 |
| - |
| - |
| 86.62 |
| 12,889 |
Turnover (€)
2025
Turnover (€)
14,880 €- *
Sales per employee (€)
14,880 €- *
Profit before tax (€)
16,351 €1,873 % *
Net Profit (€)
15,450 €1,776 % *
Profit per employee (€)
15,450 €1,776 % *
Total profitability (%)
100.00 %- *
Net profitability (%)
103.83 %- *
Equity (€)
14,151 €1,189 % *
Amounts Payable And Liabilities (€)
973 €-25 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
15,124 €1,512,300 % *
Working capital requirement
0.95 - *
Debt-to-equity ratio
0.07 107.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
86.62 %- *
EBIT (€)
12,889 €1,498 % *
